Skip to content
LeanGard®
  • Leangard®
    • Introduction
    • Mechanism of action
    • Rationale of composition
  • Research
    • Clinical evidence
  • IP Rights
    • Patents
  • Newsroom
    • Press Releases
    • Media Coverage
    • Ads
  • About Sabinsa
  • Contact Us

Sabinsa Builds Science Behind Weight Loss Blend

Sabinsa’s weight management ingredient, LeanGard, may boost weight loss and cut body fat,according to a new study from the company that builds the science behind the product.

Supplementation with the proprietary ingredient blend led to 6.4 percent greater weight loss, and a 6.97 percent greater loss of body fat than placebo, according to results from the randomised, double blind, parallel-controlled study.

Lakshmi Prakash, PhD, VP innovation and business development at Sabinsa told NutraIngredients that the study has not yet been published in a peer reviewed journal, but an article is being prepared for publication in the near future. NutraIngredients.com has not seen the full data.

The study sees the company build the science behind its blended ingredient – a necessary endeavour if the company wants to stand out in an increasingly competitive weight loss market.

Approximately one third of Americans are obese and Euromonitor International estimates the US weight management supplements market to be worth $3.93bn, while the European market is valued at $0.93bn in 2005.

LeanGard is a blend of ForsLean, Garcitrin and Bioperine. The first is an extract derived from Coleus forskohlii roots and reportedly helps to build lean body mass and optimize body composition through cAMP (cyclic adenosine monophosphate) activation.

Garcitrin contains calcium salt hydroxycitric acid (HCA) and garcinol, a polyisoprenylated benzophenone isolated from Garcinia cambogia and Garcinia indica. These fruits are thought to reduce fatty acid, lipid synthesis as well as to improve lean body mass. Standardized piperine Bioperine is extracted from black pepper and is claimed to increase the absorption of
nutrients in nutritional supplement formulations.

New data
The researchers, led by Noor Khan, MD, from Shifaa Hospital in Bangalore, India, recruited 50 overweight and obese subjects, (26 women) aged between 25 and 55, and randomly assigned them to receive either a daily dose of the proprietary blend (500 mg) or placebo for 12 weeks.

At the end of the study period, 90 per cent of participants in the LeanGard group achieved more than five per cent reduction in body weight, while no one in the placebo group achieved this weight loss. This translated to a 7.45 per cent reduction in BMI, compared to a 1.09 per cent change in the placebo group.

An increase in the basal metabolic rate (BMR) of 4.5 per cent was also observed in the LeanGard group, while people in the placebo group experienced at a 0.64 per cent mean increase.

The ingredient was first presented at the Slimming Ingredients, Germany conference in March 2007.

Back

About Sabinsa

Sabinsa is a manufacturer, supplier and marketer of herbal extracts, cosmeceuticals, minerals, dietary supplements and specialty fine chemicals for the nutritional, cosmetic, pharmaceutical and food industries.

Read More..

Headquarters

Sabinsa Corporation

20 Lake Drive 

East Windsor

NJ 08520, USA

 

Tel : +1 732 777 1111

Fax: +1 732 777 1443

info@sabinsa.com

Global Contact List

USA India
Utah, USA Japan
Australia Poland
Brasil South Korea
Canada South Africa
China Vietnam
Germany  

Contact us

    © 2022 Sabinsa. All Rights Reserved | Powered by Edkal Technologies | Privacy Policy | Sitemap | Terms of Use | Disclaimer

    ×

    Disclaimer

    US-FDA: This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

    Usage disclaimer: The information pertaining to any marketing materials by Sabinsa, is for general purposes only. Users are urged to check the validity of patents if any, on any Sabinsa items for their intended use.

    EFSA: This statement has not been evaluated by the EFSA. This product is not intended to diagnose, treat, cure, or prevent any disease.

    Australia: Please note as an ingredient supplier the information contained in this website is for marketers of finished products formulations and is not intended as consumer advice. Marketers should ensure finished products are lawful and comply with the regulations of the countries in which these items are sold. Every care has been taken to ensure the accuracy of the information provided at the time of publication.